CMF1 Endocrine Tumor Genetics: Challenging Issues

Program: Case Management Forums
Clinical Session
Friday, April 1, 2016: 2:15 PM-3:00 PM
Room 258 (BCEC)
Friday, April 1, 2016: 3:30 PM-4:15 PM
Room 258 (BCEC)
Márta Korbonits, MD, PhD, Barts and The London School of Medicine, London, United Kingdom and Tobias Else, MD, University of Michigan, Ann Arbor, MI

MK: Advisory Group Member, Pfizer, Inc., Investigator, Pfizer, Inc., Investigator, Novartis Pharmaceuticals, Advisory Group Member, AeternaZentaris. Nothing to Disclose: TE
See more of: Case Management Forums


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire